Neo-Precision Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
IPO
- Investors
-
1
Neo-Precision Therapeutics General Information
Description
NPT Co Ltd is engaged in the Clinical development of new drugs and treatments for personalized medicine.
Contact Information
Website
www.neopt.jpCorporate Office
- Room 9, 16th floor, TOC Ariake East Tower
- 3-5-7 Ariake, Koto-ku
- Tokyo, 135-0063
- Japan
Corporate Office
- Room 9, 16th floor, TOC Ariake East Tower
- 3-5-7 Ariake, Koto-ku
- Tokyo, 135-0063
- Japan
Neo-Precision Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. IPO | 30-Jan-2025 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 27-Aug-2023 | Completed | Generating Revenue |
Neo-Precision Therapeutics Patents
Neo-Precision Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024237261-A1 | Eukaryotic cell, method for producing eukaryotic cell, and pharmaceutical composition | Inactive | 14-May-2023 | ||
| US-20250223322-A1 | Parasporin expression vector and pharmaceutical composition | Pending | 15-Jul-2022 | ||
| WO-2024014560-A1 | Parasporin expression vector and pharmaceutical composition | Inactive | 15-Jul-2022 | ||
| JP-7708411-B2 | Method for preparing dendritic cells by cluster-controlled culture | Active | 09-Dec-2020 |
Neo-Precision Therapeutics Signals
Neo-Precision Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nippon Shinyaku | Corporation | Minority |
Neo-Precision Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
Neo-Precision Therapeutics FAQs
-
When was Neo-Precision Therapeutics founded?
Neo-Precision Therapeutics was founded in 2018.
-
Where is Neo-Precision Therapeutics headquartered?
Neo-Precision Therapeutics is headquartered in Tokyo, Japan.
-
What is the size of Neo-Precision Therapeutics?
Neo-Precision Therapeutics has 7 total employees.
-
What industry is Neo-Precision Therapeutics in?
Neo-Precision Therapeutics’s primary industry is Drug Discovery.
-
Is Neo-Precision Therapeutics a private or public company?
Neo-Precision Therapeutics is a Private company.
-
What is Neo-Precision Therapeutics’s current revenue?
The current revenue for Neo-Precision Therapeutics is .
-
Who are Neo-Precision Therapeutics’s investors?
Nippon Shinyaku has invested in Neo-Precision Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process